17z · Investment Firm
Investing from first principles.
17z backs the technologies and medicines that move the world forward — across venture, pre-IPO, public and private equity, and credit.
Scroll
We reason from first principles — and invest to participate in making the world a better place.
Every position begins with the fundamentals: the physics of the technology, the economics of the business, and the durability of its advantage. We are drawn to companies that compound human progress — and we hold them with conviction, in whatever form of capital fits best.
Three commitments,
held without compromise.
First-principles rigor
We do our own work. Theses are built from primary evidence and fundamental analysis, not consensus — and revised without ego when the facts change.
Technology that endures
We invest in the infrastructure and platforms of the next decades — computing, intelligence, and the systems the modern economy runs on.
Medicine that matters
We back innovative medicine and medical equipment: therapies, devices, and diagnostics that measurably extend and improve human life.
Across the full arc
of a company's life.
Venture Capital
Early conviction in founders solving hard problems, with capital and patience through the formative years.
Late-Stage & Pre-IPO
Positions in category leaders as they approach the public markets, sourced through primary and secondary channels.
Public & Private Equity
Concentrated ownership in exceptional businesses — listed or private — held with a long-term owner's mindset.
Credit
Structured and opportunistic credit where downside is protected and lenders are well compensated for the risk taken.
Equity and debt,
chosen deliberately.
Equity
Ownership when the upside is asymmetric — from first cheques to public-market positions. We size for conviction and hold through cycles.
Debt
Credit when structure serves the outcome — senior, structured, or opportunistic — providing capital where terms and protections align.
Stay in contact.
Leave your information — and your deck, if you have one. We respond to every serious inquiry.